AMLOSTIN 10MG TABLETS
Active substance: AMLODIPINE MALEATE
View full screen / Print PDF » Download PDF ⇩
Transcript
GEN-AML-DSC-PIL-214_01 27/11/12
4. POSSIBLE SIDE-EFFECTS Like all medicines, Amlostin can cause side-effects, although not everybody gets them. Visit your doctor immediately if you experience any of the following very rare, severe side-effects after taking this medicine. sudden wheeziness, chest pain, shortness of breath or difficulty in breathing swelling of eyelids, face or lips swelling of the tongue and throat which causes great difficulty breathing severe skin reactions including intense skin rash, hives, reddening of the skin over your whole body, severe itching, blistering, peeling and swelling of the skin, inflammation of mucous membranes (Stevens-Johnson syndrome) or other allergic reactions heart attack, abnormal heartbeat inflamed pancreas which may cause severe abdominal and back pain accompanied with feeling very unwell. The following common side-effects have been reported. If any of these cause you problems or if they last for more than one week, you should contact your doctor. Common (affects 1 to 10 users in 100): headache, dizziness, sleepiness (especially at the beginning of treatment) palpitations (awareness of your heartbeat), flushing abdominal pain, feeling sick (nausea) ankle swelling (oedema), tiredness. Other side-effects that have been reported include the following list. If any of these get serious, or if you notice any side-effects not listed in this leaflet, please tell your doctor or pharmacist. Uncommon (affects 1 to 10 users in 1,000): mood changes, anxiety, depression, sleeplessness trembling, taste abnormalities, fainting, weakness numbness or tingling sensation in your limbs; loss of pain sensation visual disturbances, double vision, ringing in the ears low blood pressure sneezing/running nose caused by inflammation of the lining of the nose (rhinitis) altered bowel habits, diarrhoea, constipation, indigestion, dry mouth, vomiting (being sick) hair loss, increased sweating, itchy skin, red patches on skin, skin discolouration disorder in passing urine, increased need to urinate at night, increased number of times of passing urine inability to obtain an erection; discomfort or enlargement of the breasts in men weakness, pain, feeling unwell joint or muscle pain, muscle cramps, back pain weight increase or decrease. Rare (affects 1 to 10 users in 10,000): confusion. Very rare (affects less than 1 user in 10,000): decreased numbers of white blood cells, decrease in blood platelets which may result in unusual bruising or easy bleeding (red blood cell damage) excess sugar in blood (hyperglycaemia) a disorder of the nerves which can cause weakness, tingling or numbness cough, swelling of the gums abdominal bloating (gastritis) abnormal liver function, inflammation of the liver (hepatitis), yellowing of the skin (jaundice), liver enzyme increase which may have an effect on some medical tests increased muscle tension inflammation of blood vessels, often with skin rash sensitivity to light disorders combining rigidity, tremor, and/or movement disorders. If any of the side-effects gets serious, or if you notice any side-effects not listed in this leaflet, please tell your doctor or pharmacist. 5. HOW TO STORE AMLOSTIN TABLETS Keep out of the reach and sight of children. Do not use your medicine after the expiry date which is stated on the pack after 'EXP'. The expiry date refers to the last day of that month. Do not store above 25C. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What Amlostin Tablets contain Amlostin 5mg Tablets The active substance is amlodipine (in the form of amlodipine maleate); each tablet contains an amount of amlodipine maleate corresponding to 5mg amlodipine. The other ingredients are: lactose monohydrate, povidone K30, povidone K90, microcrystalline cellulose (E460), crospovidone, sodium stearyl fumarate. Amlostin 10mg Tablets The active substance is amlodipine (in the form of amlodipine maleate); each tablet contains an amount of amlodipine maleate corresponding to 10mg amlodipine The other ingredients are: lactose monohydrate, povidone K30, povidone K90, microcrystalline cellulose (E460), crospovidone, sodium stearyl fumarate. What Amlostin Tablets look like and contents of the pack Amlostin 5mg Tablets: Amlostin 5mg Tablets are white, round tablets. The tablets are packed in cartons containing aluminium-aluminium blister packs with 10, 20, 28, 30, 50, 98, 100 and 300 (10 x 30) tablets. Amlostin 10mg Tablets: Amlostin 10mg Tablets are white, round tablets with a break score on both sides. The tablets can be divided into equal halves. The tablets are packed in cartons containing aluminium-aluminium blister packs with 10, 20, 28, 30, 50, 98 and 100 tablets. Not all pack sizes may be marketed.
POM
PL 06831/0106 PL 06831/0107 Amlostin 5mg Tablets Amlostin 10mg Tablets
Marketing Authorisation Holder: Genus Pharmaceuticals, Park View House, 65 London Road, Newbury, Berkshire RG14 1JN, UK. Manufacturer: Pharmathen S.A., 6 Dervenskion Street 153 51, Pallini Attikis, Greece. STADA Arzneimittel AG, Stadastrae 2 18, 61118 Bad Vilbel, Germany. Distributed by: Discovery Pharmaceuticals, The Old Vicarage, Market Place, Castle Donington, Derbyshire DE74 2JB, UK. This leaflet was last approved in March 2012.
9243351 1211
GEN-AML-DSC-PIL-214_01 27/11/12
Product Title Strength/Form Format Type of Print No. of Colours
Genus Amlostin (Disc) 5mg & 10mg Tabs 160 x 420 mm LITHO 1
Date Created 27/11/2012 Type (carton etc) LEAFLET Country UK Job No: GEN/AML-DSC/PIL/214
No. of Draft _01
Date 27/11/2012
Reason for Draft New file
PANTONE Black
Typefaces Helvetica 55 Roman, Helvetica 75 Bold Artwork prepared by David Heaton +44 (0)1462 431277 dc.heaton@ntlworld.com
Important. Please ensure that the texts and layout are to your satisfaction as David Heaton cannot accept liability for any errors overlooked once this proof has been signed and returned. All Bar Codes and Braille text must be verified by the client/manufacturer/printer. David Heaton is unable to do this and cannot accept liability for any errors. Colours may not reproduce accurately on this proof. You should refer to Pantone Reference Guides for an accurate colour match.
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

